Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Return on Assets (2024 - 2025)

Historic Return on Assets for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Q3 2025 value amounting to 0.29%.

  • Day One Biopharmaceuticals' Return on Assets rose 900.0% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.43% for FY2024, which is 900.0% up from last year.
  • As of Q3 2025, Day One Biopharmaceuticals' Return on Assets stood at 0.29%, which was up 900.0% from 0.18% recorded in Q2 2025.
  • Day One Biopharmaceuticals' 5-year Return on Assets high stood at 0.12% for Q2 2023, and its period low was 0.76% during Q2 2024.
  • Over the past 3 years, Day One Biopharmaceuticals' median Return on Assets value was 0.33% (recorded in 2024), while the average stood at 0.36%.
  • Per our database at Business Quant, Day One Biopharmaceuticals' Return on Assets tumbled by -6400bps in 2024 and then surged by 5800bps in 2025.
  • Over the past 3 years, Day One Biopharmaceuticals' Return on Assets (Quarter) stood at 0.37% in 2023, then increased by 7bps to 0.35% in 2024, then grew by 15bps to 0.29% in 2025.
  • Its Return on Assets stands at 0.29% for Q3 2025, versus 0.18% for Q2 2025 and 0.32% for Q1 2025.